Page last updated: 2024-10-28

ifosfamide and Barrett Esophagus

ifosfamide has been researched along with Barrett Esophagus in 1 studies

Barrett Esophagus: A condition with damage to the lining of the lower ESOPHAGUS resulting from chronic acid reflux (ESOPHAGITIS, REFLUX). Through the process of metaplasia, the squamous cells are replaced by a columnar epithelium with cells resembling those of the INTESTINE or the salmon-pink mucosa of the STOMACH. Barrett's columnar epithelium is a marker for severe reflux and precursor to ADENOCARCINOMA of the esophagus.

Research Excerpts

ExcerptRelevanceReference
" We report a patient who was cured of metastatic adenocarcinoma in Barrett's oesophagus by six courses of ifosfamide, a chemotherapeutic agent with little or no activity in other patients with adenocarcinoma of the oesophagus or gastro-oesophageal junction."3.71Cure of Barrett's carcinoma by ifosfamide chemotherapy. ( Hage, M; Kok, TC; Kuipers, EJ; Siersema, PD; Tilanus, HW; van Dekken, H; van der Gaast, A, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Siersema, PD1
Hage, M1
van der Gaast, A1
van Dekken, H1
Kok, TC1
Tilanus, HW1
Kuipers, EJ1

Other Studies

1 other study available for ifosfamide and Barrett Esophagus

ArticleYear
Cure of Barrett's carcinoma by ifosfamide chemotherapy.
    European journal of gastroenterology & hepatology, 2002, Volume: 14, Issue:11

    Topics: Adenocarcinoma; Aged; Antineoplastic Agents, Alkylating; Barrett Esophagus; Esophageal Neoplasms; Fo

2002